Hyperlipidemia in Patients with Calcific Tendinitis

Basit Öğe Kaydı
dc.authoridpolat, esra/0000-0002-2330-2816
dc.contributor.authorPolat, Esra
dc.contributor.authorOzyer, Fatih
dc.contributor.authorYuce, Elif Ilkay
dc.contributor.authorInanc, Ibrahim Halil
dc.date.accessioned2025-01-21T16:41:39Z
dc.date.available2025-01-21T16:41:39Z
dc.date.issued2022
dc.departmentKırıkkale Üniversitesi
dc.description.abstractObjective: Calcific tendinitis is a disease of unclear etiology and is associated with metabolic diseases. Hyperlipidemia, one of the metabolic diseases with systemic effects, may be associated with tendinopathy and tendinitis. In this study, we aimed to evaluate the relationship between hyperlipidemia and hypertriglyceridemia, calcific tendinitis, the location of tendinitis, and the frequency of severely symptomatic tendinitis attacks. Methods: This retrospective study included a total of 2055 patients diagnosed with calcific tendinitis between August 1, 2019, and August 1, 2021. The patients were evaluated in terms of their hyperlipidemia and hypertriglyceridemia status, statin and/or fibrate use, and the frequency of tendinitis, and the location of attack. Results: It was observed that 64.4% (n = 230) of the patients had hyperlipidemia and 11.8% (n = 42) had hypertriglyceridemia. It was determined that the most common tendinitis area among 357 patients was the shoulder. There was no statistically significant difference between the frequency of attacks (P = .712), and the location of attack (P = .069) in patients with hyperlipidemia. There was no statistically significant difference between the frequency of attacks (P = .735) and the location of attack (P = .286) in patients with hypertriglyceridemia. However, a statistically significant difference was found between the attack area (P = .032) in patients with triglyceride values higher than the target recommended values. Conclusion: The frequency of hyperlipidemia is high in patients with calcific tendinitis; it will be useful to evaluate patients with calcific tendinitis in terms of hyperlipidemia.
dc.identifier.doi10.5152/EurJTher.2022.22040
dc.identifier.endpage170
dc.identifier.issn2564-7784
dc.identifier.issn2564-7040
dc.identifier.issue3
dc.identifier.startpage166
dc.identifier.urihttps://doi.org/10.5152/EurJTher.2022.22040
dc.identifier.urihttps://hdl.handle.net/20.500.12587/24906
dc.identifier.volume28
dc.identifier.wosWOS:000865982700001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherAves
dc.relation.ispartofEuropean Journal of Therapeutics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241229
dc.subjectCalcific tendinitis; hyperlipidemia; hypertriglyceridemia; LDL; shoulder
dc.titleHyperlipidemia in Patients with Calcific Tendinitis
dc.typeArticle

Dosyalar

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu